Table 4 In-hospital management of the 216 included patients, and comparison according to the consumption of anti-inflammatory drugs prior to admission
Total population | No AID | AID | AID vs. no AID | NSAID | NAID vs. no AIDa | CT | Corticosteroids vs. no AIDa | NSAID vs. corticosteroidsa | |
|---|---|---|---|---|---|---|---|---|---|
p-value | p-value | p-value | p-value | ||||||
n | 216 | 89 (41.2 %) | 127 (58.7 %) | 76 (35.2 %) | 67 (31.0 %) | ||||
Paraclinical tests | |||||||||
CT-scan | 77 (35.6 %) | 38 (42.7 %) | 39 (30.7 %) | 0.070 | 23 (30.3 %) | 0.305 | 19 (28.4 %) | 0.185 | 0.842 |
Abscess volume (cm3) | 4.4 (1.6–10.2) | 2.9 (0.9–7.8) | 6.8 (3.7–12.7) | 0.005 | 5.7 (3.2–10.6) | 0.028 | 7.1 (1.9–13.5) | 0.049 | 0.728 |
CRP (mg/L) | 90.0 (44.4–156.5) | 109.5 (66.9–172.8) | 72.4 (38.3–133.0) | 0.002 | 95.1 (50.9–181.0) | 0.663 | 47.5 (26.5–81.5) | <10−3 | <10−3 |
WBC (/mm3) | 14,400 (12,100–17,700) | 13,500 (12,000–16,200) | 15,400 (12,50–18,300) | 0.031 | 15,600 (12,600–17,700) | 0.131 | 15,500 (12,500–19,100) | 0.111 | 0.605 |
Neutrophils (/mm3) | 13,600 (10,100–16,200) | 12,800 (9400–15,600) | 14,100 (10,400–16,500) | 0.326 | 14,200 (11,300–15,600) | 0.437 | 14,100 (10,300–17,000) | 0.454 | 0.927 |
Hospitalisation | 215 (99.5 %) | 88 (98.9 %) | 127 (100.0 %) | 0.412 | 76 (100.0 %) | 1.000 | 67 (100.0 %) | 1.000 | NC |
Hospital stay (d) | 3.0 (3.0–4.0) | 3.0 (3.0–4.0) | 3.0 (3.0–4.0) | 0.170 | 3.0 (3.0–4.0) | 0.492 | 3.0 (3.0–4.0) | 0.066 | 0.344 |
ICU | 3 (1.4 %) | 1 (1.1 %) | 2 (1.6 %) | 1.000 | 2 (2.6 %) | 0.565 | 0 (0.0 %) | 1.000 | 0.499 |
Surgical management | 203 (94 %) | 83 (93.3 %) | 120 (94.5 %) | 0.708 | 73 (96.1 %) | 0.740 | 63 (94 %) | 1.000 | 0.539 |
Puncture/Incision | 199 (92.1 %) | 82 (92.1 %) | 117 (92.1 %) | 0.998 | 71 (93.4 %) | 0.918 | 62 (92.5 %) | 0.693 | 0.787 |
Productive puncture | 152 (70.4 %) | 56 (62.9 %) | 96 (75.6 %) | 0.045 | 58 (76.3 %) | 0.268 | 53 (79.1 %) | 0.160 | 0.831 |
Initial | 199 (92.1 %) | 82 (92.1 %) | 117 (92.1 %) | 0.998 | 71 (93.4 %) | 0.918 | 62 (92.5 %) | 0.758 | 0.787 |
Secondary | 80 (37 %) | 34 (38.2 %) | 46 (36.2 %) | 0.767 | 31 (40.8 %) | 0.849 | 24 (35.8) | 0.294 | 0.419 |
Surgery under GA | 21 (9.7 %) | 9 (10.1 %) | 12 (9.4 %) | 0.871 | 10 (13.2 %) | 0.982 | 6 (9.0 %) | 0.328 | 0.217 |
Initial | 5 (2.3 %) | 1 (1.1 %) | 4 (3.1 %) | 0.330 | 3 (3.9 %) | 0.346 | 2 (3.0 %) | 1.000 | 1.000 |
Secondary | 18 (8.3 %) | 8 (9.0 %) | 10 (7.9 %) | 0.806 | 9 (11.8 %) | 0.836 | 4 (6.0 %) | 0.155 | 0.122 |
Cervicotomy | 2 (0.9 %) | 0 (0.0 %) | 2 (1.6 %) | 0.513 | 2 (2.6 %) | 0.161 | 0 (0.0 %) | NC | 0.499 |
Tonsillectomy | 12 (5.6 %) | 4 (4.5 %) | 8 (6.3 %) | 0.765 | 7 (9.2 %) | 0.715 | 4 (6.0 %) | 0.653 | 0.372 |
Iterative procedure | 93 (43.1 %) | 39 (43.8 %) | 54 (42.5 %) | 0.849 | 38 (50.0 %) | 0.887 | 27 (40.3 %) | 0.147 | 0.142 |
Medical management | |||||||||
IV antimicrobial therapy | 214 (99.1 %) | 88 (98.9 %) | 126 (99.2 %) | 1.000 | 75 (98.7 %) | 0.410 | 66 (98.5 %) | 1.000 | NC |
Total duration (d) | 12.5 (11.0–15.0) | 12.0 (11.0–15.0) | 13.0 (10.0–16.0) | 0.249 | 12.0 (10.0–15.3) | 0.203 | 14.0 (12.0–17.5) | 0.046 | 0.007 |
From hospital admission (d) | 10.0 (10.0–11.0) | 10.0 (10.0–12.0) | 10.0 (10.0–11.0) | 0.021 | 10.0 (10.0–11.0) | 0.204 | 10.0 (10.0–11.0) | 0.008 | 0.176 |